Kiromic Biopharma, Inc.
KRBPDelisted Nov 20, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001792581
Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Kiromic Biopharma, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q2 2022
- Shares held
- 322.1K
- −153.0K (−32.2%) vs. Q2 2022
- Total value
- $90.3K
- −$109.7K (−54.8%) vs. Q2 2022
- New holders
- 5
- 4 more added
- Sold out
- 6
- 3 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 5 | $6.13K |
| Q1 2023 | 7 | $78.2K |
| Q4 2022 | 12 | $145.5K |
| Q3 2022 | 16 | $90.3K |
| Q2 2022 | 17 | $200.0K |
| Q1 2022 | 20 | $1.73M |
| Q4 2021 | 21 | $3.82M |
| Q3 2021 | 23 | $7.49M |
| Q2 2021 | 16 | $11.9M |
| Q1 2021 | 13 | $3.34M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Kiromic Biopharma, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Zeke Capital Advisors, LLC | 107,000 | $31.0K | 0.00% | 00.0% | Unchanged |
| Redmond Asset Management, LLC | 41,758 | $12.0K | 0.00% | −2,634−5.9% | Reduced |
| Citadel Advisors LLC | 39,865 | $12.0K | 0.00% | +20,171+102.4% | Added |
| Geode Capital Management, LLC | 40,962 | $11.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 16,976 | $5.00K | 0.00% | +290+1.7% | Added |
| UBS Group AG | 18,510 | $5.00K | 0.00% | +13,355+259.1% | Added |
| StoneX Group Inc. | 15,000 | $4.35K | 0.00% | +15,000 | New |
| Two Sigma Securities, LLC | 11,052 | $3.00K | 0.00% | −38,821−77.8% | Reduced |
| Cetera Advisor Networks LLC | 10,509 | $3.00K | 0.00% | +10,509 | New |
| WealthTrust Axiom LLC | 10,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,874 | $1.00K | 0.00% | −46−0.9% | Reduced |
| The PNC Financial Services Group, Inc. | 4,000 | $1.00K | 0.00% | +4,000 | New |
| Morgan Stanley | 1,200 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 75 | $0 | 0.00% | +33+78.6% | Added |
| Group One Trading, L.P. | 192 | $0 | 0.00% | +192 | New |
| Simplex Trading, LLC | 100 | $0 | 0.00% | +100 | New |
| HRT Financial LP | 0 | $0 | 0.00% | −78,854−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −31,602−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,970−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −17,300−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,285−100.0% | Sold out |